Paradi Mirmirani MD
Department of Dermatology, Assistant Chief, Regional Director, Hair Disorders, Kaiser Permanente Vallejo; Local Research Chair, Napa Solano, Vallejo, CaliforniaDr. Paradi Mirmirani completed residencies in Internal Medicine and Dermatology, and a clinical hair research fellowship at the University of California San Francisco. Since then, hair disorders have remained the focus of her clinical and research activities. Dr. Mirmirani is practicing at the Kaiser Permanente Medical Center in Vallejo, California, where she serves as the Northern California regional referral center for hair disorders.
Disclosures
Paradi Mirmirani is an investigator for Eli-Lilly, Concert Pharmaceuticals and Pfizer for clinical trial of alopecia areata.
Recent Contributions to PracticeUpdate:
- Consensus Recommendations on Treatments for Central Centrifugal Cicatricial Alopecia
- Effectiveness of Tofacitinib for the Treatment of Pre-Adolescent Alopecia Areata
- Efficacy and Outcomes of Uptitrating Baricitinib Therapy in Patients With Severe Alopecia Areata
- Major Improvement of Very Severe Alopecia Areata in Patients Treated With the Combination of Baricitinib and Low Doses of Corticosteroids
- Adverse Events in Patients With Alopecia Areata Treated With JAK Inhibitors
- Low-Dose Oral Minoxidil Improves Hair Density in Patients With Traction Alopecia
- JAK Inhibitors, Biologics, and Phosphodiesterase-4 Inhibitors for the Management of Alopecia Areata in Adults
- Shared Decision–Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Predictors of Quality of Life in Patients With Alopecia Areata
- Dutasteride Intralesional Microinjections in Combination With Oral Minoxidil vs Oral Minoxidil Monotherapy in Men With Androgenetic Alopecia